# Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?

> **NCT02903082** · — · TERMINATED · sponsor: **University Hospital, Limoges** · enrollment: 68 (actual)

## Conditions studied

- Severe Sepsis
- Inflammatory Response Syndrome, Systemic

## Interventions

- **BIOLOGICAL:** Residue of blood further to NFS
- **BIOLOGICAL:** Residue of blood further to preoperative workup
- **BIOLOGICAL:** Bone marrow collected during a myelogram carried out for hematological pathology workup
- **BIOLOGICAL:** Bone marrow collected during myelogram routinely performed during hospitalization in ICU

## Key facts

- **NCT ID:** NCT02903082
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2015-04
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2019-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02903082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02903082, "Following of Myeloid-derived Suppressor Cells (MDSC) in Severe Sepsis: What Relationship With Systemic Inflammatory Syndrome?". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02903082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*